Baker Ellis Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $468K | Sell |
1,052
-221
| -17% | -$98.4K | 0.06% | 146 |
|
|
2025
Q1 | $617K | Buy |
1,273
+215
| +20% | +$104K | 0.09% | 134 |
|
|
2024
Q4 | $426K | Buy |
1,058
+320
| +43% | +$129K | 0.06% | 152 |
|
|
2024
Q3 | $343K | Sell |
738
-32
| -4% | -$14.9K | 0.05% | 177 |
|
|
2024
Q2 | $361K | Buy |
770
+160
| +26% | +$75K | 0.05% | 162 |
|
|
2024
Q1 | $255K | Buy |
+610
| New | +$255K | 0.04% | 191 |
|